InsiderTrades.com logo

MIRA Insider Trading

Insider Ownership Percentage: 19.89%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

MIRA Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at MIRA Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

MIRA Pharmaceuticals Share Price & Price History

Current Price: $0.90
Price Change: ▲ Price Increase of +0.0605 (7.21%)
As of 09/25/2026 04:00 PM ET

This chart shows the closing price history over time for MIRA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

MIRA Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/19/2024Erez AminovCEOSell55,410$1.39$77,019.901,105,790View SEC Filing Icon  
5/21/2024Erez AminovCEOBuy8,700$0.94$8,178.00382,200View SEC Filing Icon  
12/11/2023Brian Patrick McnultyMajor ShareholderSell46,005$1.55$71,307.75660,000View SEC Filing Icon  
12/8/2023Brian Patrick McnultyMajor ShareholderSell19,053$1.61$30,675.33683,002View SEC Filing Icon  
12/6/2023Brian Patrick McnultyMajor ShareholderSell27,733$2.95$81,812.35709,196View SEC Filing Icon  
12/4/2023Brian Patrick McnultyMajor ShareholderSell61,331$3.98$244,097.38723,062View SEC Filing Icon  
11/29/2023Brian Patrick McnultyMajor ShareholderSell7,399$3.98$29,448.02756,149View SEC Filing Icon  
11/27/2023Brian Patrick McnultyMajor ShareholderSell6,425$4.00$25,700.00759,969View SEC Filing Icon  
11/20/2023Brian Patrick McnultyMajor ShareholderSell26,733$5.07$135,536.31765,681View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for MIRA Pharmaceuticals (NASDAQ:MIRA)

35.16% of MIRA Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at MIRA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

MIRA Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/7/2026BlackRock Inc.244,622$0.23M0.0%N/A0.582%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd20,904$32K0.0%-41.8%0.050%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC272,878$0.41M0.0%+100.0%0.652%Search for SEC Filing on Google Icon
2/2/2026Fifth Third Bancorp20,000$30K0.0%N/A0.048%Search for SEC Filing on Google Icon
1/20/2026First American Bank60,000$91K0.0%+20.0%0.143%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP45,703$62K0.0%+129.8%0.240%Search for SEC Filing on Google Icon
10/20/2025First American Bank50,000$68K0.0%+150.0%0.262%Search for SEC Filing on Google Icon
8/12/2025XTX Topco Ltd21,873$26K0.0%N/A0.129%Search for SEC Filing on Google Icon
8/8/2025Creative Planning22,599$27K0.0%N/A0.134%Search for SEC Filing on Google Icon
7/29/2025International Assets Investment Management LLC35,000$42K0.0%N/A0.207%Search for SEC Filing on Google Icon
4/22/2025Suncoast Equity Management103,289$0.10M0.0%+356.1%0.614%Search for SEC Filing on Google Icon
2/17/2025Two Sigma Investments LP24,317$28K0.0%N/A0.147%Search for SEC Filing on Google Icon
2/17/2025Citadel Advisors LLC97,976$0.11M0.0%N/A0.592%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp30,362$35K0.0%+50.9%0.183%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC45,772$52K0.0%N/A0.276%Search for SEC Filing on Google Icon
2/11/2025Virtu Financial LLC63,410$72K0.0%N/A0.383%Search for SEC Filing on Google Icon
2/3/2025Suncoast Equity Management22,644$26K0.0%-74.8%0.137%Search for SEC Filing on Google Icon
1/8/2025International Assets Investment Management LLC25,000$29K0.0%N/A0.151%Search for SEC Filing on Google Icon
10/23/2024Cross Staff Investments Inc365,901$0.48M0.4%-4.6%2.475%Search for SEC Filing on Google Icon
10/21/2024Suncoast Equity Management90,000$0.12M0.0%+125.0%0.609%Search for SEC Filing on Google Icon
5/20/2024Virtu Financial LLC63,055$69K0.0%+330.2%0.427%Search for SEC Filing on Google Icon
5/2/2024Suncoast Equity Management40,000$44K0.0%N/A0.271%Search for SEC Filing on Google Icon
5/2/2024Cross Staff Investments Inc383,401$0.42M0.4%N/A2.594%Search for SEC Filing on Google Icon
4/10/2024Praetorian Wealth Management Inc.27,500$30K0.0%N/A0.186%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
MIRA Pharmaceuticals logo
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Miami, Florida.
Read More on MIRA Pharmaceuticals

Today's Range

Now: $0.90
Low: $0.85
High: $0.90

50 Day Range

MA: $0.79
Low: $0.61
High: $0.96

52 Week Range

Now: $0.90
Low: $0.60
High: $2.45

Volume

94,205 shs

Average Volume

293,408 shs

Market Capitalization

$37.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.52

Who are the company insiders with the largest holdings of MIRA Pharmaceuticals?

MIRA Pharmaceuticals' top insider shareholders include:
  1. George Cappy (Major Shareholder)
  2. Erez Aminov (CEO)
  3. Brian Patrick Mcnulty (Major Shareholder)
Learn More about top insider investors at MIRA Pharmaceuticals.

Who are the major institutional investors of MIRA Pharmaceuticals?

MIRA Pharmaceuticals' top institutional shareholders include:
  1. BlackRock Inc. — 0.58%
Learn More about top institutional investors of MIRA Pharmaceuticals stock.

Which major investors are buying MIRA Pharmaceuticals stock?

During the last quarter, MIRA stock was purchased by institutional investors including:
  1. BlackRock Inc.

MIRA Pharmaceuticals Active Insiders

Erez Aminov
Erez Aminov (Age 48)
CEO